VGP NV

Declaration of Voting Results & Voting Rights Announcements • Apr 4, 2017

Press Release Regulated Information

Zele, 4 April 2017 – 06:00 PM CET

Disclosure in accordance with the Law of 2 May 2007: Transparency law

Transparency declaration by Mr Bart Van Malderen

VGP NV has received a transparency notification dated 4 April 2017 that Bart Van Malderen now holds, by virtue of the sale of 766,203 shares by VM Invest NV on 3 April 2017, 43.03% of the voting rights of the company. Therefore, the threshold of 45% was crossed.

The notification dated 4 April 2017 contains following information:

• Reason for notification: Acquisition or disposal of voting securities or voting rights.
• Notification by: A parent undertaking or a controlling person.
• Persons subject to the notification requirement: Bart Van Malderen; VM Invest NV, Spinnerijstraat 12, 9240 Zele.
• Date on which the threshold is crossed: 3 April 2017.
• Threshold that is crossed: 45%.
• Denominator: 18,583,050.
• Notified details:

	Previous notification	After the transaction
	Number of voting rights	Number of voting rights	% of voting rights
Bart Van Malderen	3,545,250	3,545,250	19.08%
VM Invest NV	5,159,434	4,451,668	23.96%
Total	8,704,684	7,996,918	43.03%

• Chain of controlled undertakings through which the holding is effectively held, if applicable: VM Invest NV is controlled by Mr Bart Van Malderen.

Profile

VGP (www.vgpparks.eu) constructs and develops high-end logistic real estate and ancillary offices for its own account and for the account of its VGP European Logistics joint venture (50:50 joint venture between Allianz Real Estate and VGP), which are subsequently rented out to reputable clients on long term lease contracts. VGP has an in-house team which manages all activities of the fully integrated business model: from identification and acquisition of land, to the conceptualisation and design of the project, the supervision of the construction works, contracts with potential tenants and the facility management. VGP is quoted on Euronext Brussels and the Main Market of the Prague Stock Exchange.